Our Science

The past decade has seen significant interest in the microbiome. It is now clearly established that a healthy gut microbiota is paramount to general health, with implications across a wide range of diseases.

Prevatex has licensed a suite of intellectual property covering a link between bacteria in the maternal and infant microbiomes and the risk of infants developing both food allergies and behavioural concerns in the first years of life. We are also exploring opportunities in animal health – an exciting new development.


The articles below provide insight into our research – and related studies – showing the benefits of a healthy Prevotella-based gut microbiome.

By restoring a healthy microbiome with Prevotella-based products, we have the potential to make a significant contribution to human health.”
– Co-founder and Executive Chairman, Dr Greg Collier